Antibody Binding Alters the Characteristics and Contents of Extracellular Vesicles Released by Histoplasma capsulatum

Ludmila Matos Baltazar1, Ernesto S Nakayasu2, Tiago J P Sobreira3

  • 1Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA; Division of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.

Msphere
|June 16, 2016
PubMed

Insights

Monoclonal antibodies (MAbs) targeting Histoplasma capsulatum heat shock protein 60 altered the size and protein cargo of extracellular vesicles. This antibody binding modulates fungal physiology and vesicle secretion, impacting host-pathogen interactions.

Area of Science:

  • Mycology
  • Immunology
  • Cell Biology

Background:

  • Histoplasma capsulatum releases extracellular vesicles containing virulence factors.
  • Monoclonal antibodies (MAbs) can influence fungal infection outcomes.
  • Heat shock protein 60 (Hsp60) is a target for MAbs against H. capsulatum.

Purpose of the Study:

  • To investigate how protective (MAb 6B7) and nonprotective (MAb 7B6) MAbs targeting H. capsulatum Hsp60 affect the properties of fungal extracellular vesicles.
  • To analyze changes in vesicle size, enzymatic content, and proteomic profiles upon MAb treatment.

Main Methods:

  • Treatment of H. capsulatum cells with specific MAbs (6B7 and 7B6).
  • Isolation and characterization of extracellular vesicles.
  • Analysis of vesicle size, enzymatic activities (phosphatase, catalase), and proteomic profiles.
  • Quantitative proteomics to identify differentially abundant proteins.

Main Results:

  • MAb treatment altered vesicle size and protein loading compared to untreated controls.
  • Vesicles from MAb-treated cells showed reduced phosphatase and catalase activity.
  • Proteomic analysis identified significant differences in protein cargo, with 250 proteins showing altered abundance.
  • MAb 7B6 treatment resulted in a higher abundance of upregulated proteins in vesicles compared to MAb 6B7 treatment.

Conclusions:

  • Antibody binding to H. capsulatum cells modulates fungal extracellular vesicle composition and enzymatic activity.
  • Differential protein loading in vesicles can impact fungal susceptibility to host defenses.
  • This study reveals a novel role for antibodies in altering fungal physiology and secretion pathways.

Related Concept Videos

Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
3.4K
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
85.7K
Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
67.1K
Antibody Structure and Classes01:25

Antibody Structure and Classes

Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
10.1K
Affinity and Avidity01:41

Affinity and Avidity

Overview
40.0K
Drug Binding to Blood Components01:30

Drug Binding to Blood Components

When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
631